Publications by authors named "L Bowman"

Article Synopsis
  • * In research using mice, SCD was found to enhance vasoconstriction (narrowing of blood vessels) through the alpha-1 adrenergic receptor, particularly by increasing the expression of the alpha-1a receptor in the aortic tissue of SCD mice compared to controls.
  • * Treatment with ambrisentan, an ETA receptor blocker, improved blood vessel function in both mice and SCD patients, suggesting that targeting the ET-1 pathway could help improve vascular health in individuals with
View Article and Find Full Text PDF

Background: The double-blind, 2 × 2 factorial design, placebo-controlled ASCEND randomized trial compared the effects of 100 mg aspirin daily and, separately, 1 g omega-3 fatty acids (FAs) daily on the primary prevention of cardiovascular disease in 15,480 UK adults with diabetes. We report the effects of these randomized treatment allocations on scores derived from the National Eye Institute's Visual Function Questionnaire-25 (NEI-VFQ-25) in a subset of participants involved in the ASCEND-Eye sub-study.

Methods: Ordinal data from the NEI-VFQ-25 were analyzed using proportional odds regression methods.

View Article and Find Full Text PDF

Behavioral research demonstrates a critical transition in preschooler's mental-state understanding (i.e., theory of mind; ToM), revealed most starkly in performance on tasks about a character's false belief (e.

View Article and Find Full Text PDF
Article Synopsis
  • The Limb Loss and Preservation Registry (LLPR) is a national effort in the U.S. aimed at gathering and standardizing data on patients with limb loss or limb differences.
  • Developed in collaboration with various stakeholders, it collects patient information from hospitals, providers, and patients across all 50 states.
  • The registry has successfully documented data from over 435,000 patients, enabling improved healthcare practices and guiding national policies through comprehensive data analysis.
View Article and Find Full Text PDF

Permethrin-treated clothing is often recommended as a first line of defense against tick-borne diseases. In 2012, the permethrin factory-treated Army Combat Uniform was first made available to active duty Soldiers, Army National Guard, Army Reserve Enlisted Soldiers, and the Senior/Junior Reserve Officers Training Corps. Subsequently, Air Force and Marine Corps personnel were also offered permethrin factory-treated uniforms.

View Article and Find Full Text PDF